Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2014


Biomarker Utilisation & Commercialisation

10 Sep 2014 - 11 Sep 2014 - London, UK



Bookmark and Share


The ACI Biomarker Utilisation & Commercialisation conference will take place on the 10th & 11th September in London. The event will explore the value of biomarkers from both a clinical and commercial perspective.

The aim of the event is to help end-users to develop a comprehensive strategy for biomarker discovery, development, application and analysis in clinical trials.
Attendees will get to meet renowned experts in biomarkers to discuss and debate key issues. All this takes place in a friendly environment designed to encourage networking between participants.

Topics on the agenda:
Benefit from an instructive two-day programme that explores a range of clinical and commercial factors affecting decision-makers in the world of biomarkers, combined with the opportunity for interaction with key opinion leaders.

Presentation Topics Include:
* Creating and Capturing Value with Biomarkers.
* Innovative Commercialisation of Companion Diagnostic Solutions 
* The Use of Human Genetics to Identify Novel Biomarkers for Clinical Trials
* Biomarker Discovery to Diagnostic Development: What are the Challenges? 
* Applying Imaging Biomarkers to Reduce Risk in Drug Development 
* Intellectual Property Protection for Biomarker Utilisation 
* Biomarkers in Personalised Medicine: From Discovery to Repositioning 
* Statistical Innovations in Biomarker Utilisation

Confirmed speaker companies include:
* Teva * Pfizer * Bayer Schering Pharma * Roche Diagnostics * Actelion * Comprehensive Biomarker Center GmbH * TNO * Biogerontology Research Foundation * Eisai * Westminster Genomic Services * Harrison Goddard Foote LLP * Cambridge Consultants * University College Dublin * Lloyd’s Register Quality Assurance (LRQA) * Medimmune * University College Dublin * Imanova *

For a copy of the conference programme or to register your attendance contact Cheryl Williams on +44 (0) 203 141 0623 or email cwilliams@acieu.net


Further information
Scientific News
Over Two-Thirds of Cervical Cancer Deaths Prevented
Cervical screening prevents 70% of cervical cancer deaths and if all eligible women regularly attended screening this would rise to 83%.
Detecting Bacterial Infections in Newborns
Researchers tested an alternative way to diagnose bacterial infections in infants—by analyzing RNA biosignatures from a small blood sample.
Mechanisms of Parkinson’s Pathology
Defects that lead to cells’ failure to decommission faulty mitochondria cause nerve cells to die, triggering the symptoms of Parkinson’s disease.
Case for Liquid Biopsies Builds in Advanced Lung Cancer
Study addresses unmet need for better, non-invasive tests called out in recent "Moonshot" blue ribbon panel report
Genetic Misdiagnoses of Heart Condition
Analysis found several genetic variations previously linked with a heart condition were harmless, leading to condition misdiagnosis.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Genetic Diversity of Enzymes Alters Metabolic Individuality
ToMMo scientists have shown that genetic polymorphisms, structural location of mutation and effect for phenotype correlate with each other.
IMM Uses Nanowizard® to Evaluate Cardiovascular Disease Risk
JPK Instruments reports on the use of their NanoWizard® AFM system at the Instituto de Medicina Molecular at the University of Lisbon.
$1M NIH Grant to Refine PCR Based Cancer Test
Researchers at Cornell University, Weill Cornell Medicine, the University of California, San Francisco, and the Infectious Diseases Institute in Kampala, Uganda, recieve a four-year, $1 million grant to hone technology for a quick, in-the-field diagnosis of Kaposi's sarcoma — a cancer frequently related to HIV infections.
Zika Reference Strain Sequenced
An international research team has sequenced a strain of Zika for use as a WHO reference strain.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!